| Profile for racttirabottmenberch |
|---|
|
SignatureRimonabant is an anorectic antiobesity drug that was first approved in Europe in 2006 but was withdrawn worldwide in 2008 due to serious psychiatric side effects; it was never approved in the United States. Rimonabant is an inverse agonist for the cannabinoid receptor CB1 and was . Cannabinoid type... |
